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ABSTRACT
Iodothyronine deiodinases, types I, II, and III (D1, D2, and D3)
activities were measured in tissues of fetal rats, at 18 and 21 days of
gestation, at several levels of iodine deficiency (ID): mild ID diet (MID)
and moderately severe ID, MID 1 0.005% perchlorate (MID1P). D2
was present in fetal skin, increased between days 18 and 21, and also
in MID and MID1P. In skin, D3 increased during ID at day 18,
whereas there was a decrease at day 21. Skin T4 decreased in MID and
MID1P, showing an inverse relationship with D2. Skin T3 decreased
at day 18 in MID and MID1P but increased at day 21, probably
because of the increased D2 and decreased D3, maintaining T3 con-
centrations. No effect of ID was observed on hepatic D1. D2 increased
in brain and brown adipose tissue at day 21 in MID1P. No changes
were found in maternal placental D2 and D3, but D2 and D3 increased
in the fetal placenta at day 18 in MID1P.
A higher level of D2 is present in fetal skin than in the brain. As
the activity is increased, in even mild ID (and already at 18 days) it
can be concluded that skin D2 is likely to be of considerable physio-
logical importance, at least for fetal thyroid hormone economy, by
contributing to the intracellular T3 content of the skin and, possibly,
to the plasma T3. (Endocrinology 139: 2229–2234, 1998)
T4 IS BIOACTIVATED into T3 by enzymatic deiodina-tion. T3 homeostasis in tissues is maintained by the
iodothyronine deiodinase isoenzymes, types I, II, and III
(D1, D2, and D3). Their activity is dependent on the thy-
roid (hormone) and nutritional status and is regulated by
glucocorticoids and growth factors (1, 2). The presence and
activities of these enzymes are tissue specific. D1 is found
in the liver, kidney, pituitary, and thyroid; D2 is found in
the central nervous system, pituitary, brown adipose tis-
sue (BAT), placenta, (human) thyroid, and muscle; D3 is
present in the brain, skin, placenta, and several fetal tis-
sues (1–5). The ontogenic appearance of D1 in the rat fetal
liver and lung, of D2 in the fetal brain and BAT (6 – 8), and
of D3 in the cerebral cortex (9) and in fetal tissues (2) are
well described. Changes in tissue deiodinase activity are
of great importance in those organs, which are dependent
on locally produced T3 (1– 8).
During pregnancy, thyroid hormones of maternal origin
are found in fetal rat tissues before onset of fetal thyroid
function (10–13), as well as in humans (14, 15), and are, at
present, believed to play a role in early development (16–18)
and to have a protective role when fetal thyroid function is
impaired (19), although this role is sometimes contested (20).
Until onset of its own thyroid function, the fetus is mainly
dependent on the maternal supply of T4 (10–13). During
pregnancy, T4 and T3 levels in maternal plasma and tissues
in the rat are decreased (21).
One of the situations in which thyroid function is impaired
is iodine deficiency (ID). ID is characterized by a decrease in
plasma and tissue T4 concentrations, normal or even higher
than normal plasma T3, and an increased plasma TSH. The
thyroid is enlarged (6, 22–32). There is a preferential syn-
thesis and secretion of T3 by the thyroid (23, 24), which is also
stimulated by the TSH-dependent increase in thyroid D1
activity (29, 33). This results in higher T3/T4 ratios in plasma
and tissues. In this situation, less T4 from the maternal cir-
culation is available for the fetus (6, 12, 13, 18, 27). Fetal
plasma and tissue T4 and T3 levels are lowered and D2
activity is increased in fetal brain and BAT, whereas D1
activity in liver decreased (6). Most of these studies were
performed with severely iodine-deficient rats, whose fetuses
had lowered plasma T3 levels.
Even in adult rats that were only marginally ID, with
slightly lowered plasma T4 levels, D2 activity increased in the
brain (34).
Our aim was to obtain more information about changes in
iodothyronine deiodinase activities in fetal rat tissues (brain,
BAT, liver, placenta, and skin) at degrees of ID that are more
comparable with the mild and moderate ID that affects in-
habitants in large parts of the world. We considered it of
interest to assess the capacity of the different iodothyronine
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deiodinases of the developing fetus, to respond to these
situations, and their contribution to the maintenance of T3
levels.
Because it is known that there are developmental changes
of D1, D2, and/or D3 activities during the last stage of ges-
tation, two time-points were chosen, i.e. day 18 of gestation




The experiments were approved by the local committee on animal
care. Three groups of rats (CPB/WU, Iffa Credo, Brussels, Belgium) were
used (BW, 210 6 5 g). The rats were housed at 22 C, with alternating 14-h
light, 10-h dark periods. They were fed the American Institute of Nu-
trition (AIN) diet (35), without iodine (mild iodine diet, MID). In one
group, potassium perchlorate (0.005%) was added to this diet (MID1P);
and in the third group, potassium iodide (1.5 mg/day) was added to the
diet (MID1I). This last group served as controls. After 3 months, rats
were mated, and the day that sperm was present was taken as day zero
of pregnancy. During 5 days, the rats were housed in metabolic cages.
This allowed us to collect 24-h urine and to measure the iodine excretion
according to Sandell and Kolthoff (36). At 18 and 21 days of pregnancy,
three rats were bled and perfused under light ether anesthesia. Fetal
tissues were taken and were kept frozen at 270 C until used. The skin
was taken, excluding that of the head, legs, and tail. The fetal and
maternal (basal) sides of the placenta were isolated by separation of the
two distinct layers from each other, with blunt forceps, on ice (37).
Chemicals
T4, T3, dithiothreitol (DTT), and propylthiouracil (PTU) were from
Sigma Chemical Co. (St. Louis, MO). 125I and 131I were from New
England Nuclear-Dupont (Dreieich, Germany), inner-ring labeled T3
was purchased from Formula (Berlin, Germany). Anion exchange
resins Dowex AG 1X2 and 50WX2 were obtained from Bio-Rad
(Richmond, CA).
Determinations of plasma TSH, T3, and T4 in plasma
and skin
In plasma, the concentrations of T4 and T3 were assayed by rat-specific
RIA (38). Plasma TSH was measured by the specific RIA developed for
the rat by the NIDDK (NIH, Bethesda, MD). Reference preparation-2 was
used as a standard.
In skin, thyroid hormones were determined as previously described
in detail for rat tissues (39). The fetal skin was frozen in liquid nitrogen
and crushed to a fine powder while frozen. The powder was taken up
quantitatively and homogenized in methanol, after which the procedure
of extraction and purification used for other tissues was followed.
Determination of 59-D1, D2, and D3 activities
For determination of D1, D2, and D3 activity the release of [125Iodide]
from [125I]-labeled substrates was measured using homogenates.
Before use, the labeled substrates were purified by paper electro-
phoresis, to separate them from the contaminating iodide. The contri-
bution of the mass of radioactive substrates added was taken into ac-
count for calculation of the total substrate concentrations. After the
reaction, the [125I] iodide released was separated, by ion exchange chro-
matography, on Dowex 50W-X2 columns, as previously described (6–8,
40). The protein content was measured by the method of Lowry et al. (41).
The conditions were as set forth below.
For D1. [125I]rT3 (60.000 cpm/tube) was used in the presence of 200 nm
rT3 and 2 mm DTT, after 15 min incubation at 37 C, using 20–50 mg
protein/100 ml.
For D2. [125I]T4 (60,000 cpm/tube) was used in the presence of 2 nm T4,
1 mm T3, 20 mm DTT, and 1 mm PTU, after 1 h incubation at 37 C; 150–200
mg protein/100 ml was used (42). For skin, we checked with paper
chromatography and found that equal molar amounts of iodide and T3
were released. Endogenous T4 from the skin contributed less than 2% to
the total substrate concentration.
For D3. [125I, 3]T3 (60,000 cpm/tube) was used in the presence of 20 nm
T3, 20 mm DTT, and 1 mm PTU, after 1 h incubation at 37 C; 30–50 mg
protein/100 ml was used.
Statistics
Mean values 6 se are given. Statistical analysis was performed by
ANOVA (43), and differences between mean values were considered
statistically significant at P # 0.05.
The program SPSS 6.1 (Real Stats, Real Easy, Chicago, IL) was used
for comparison of the slopes of the linear regression.
Results
The experimental model chosen provided three levels of
iodine intake: normal iodine intake (MID1I), moderate
(MID), and low iodine intake (MID1P). The daily urinary
iodine excretion was: 1.62 6 0.08 mg (MID1I); 0.42 6 0.04 mg
(MID); and 0.60 6 0.05 mg (MID1P). The excretion of iodine
in MID1P is higher than that in MID because the uptake of
iodide, not only from the diet but also from thyroid hormone
metabolism, is completely blocked by perchlorate, whereas
in MID, part of this iodide can be reused for thyroid hormone
synthesis. The maternal BW (at day 18: 296 6 8 g; at day 21:
321 6 6 g) and the number and weight of fetuses were not
influenced by MID and MID1P (data not shown). The ma-
ternal thyroids were enlarged in MID1P (58.0 6 5.5 mg),
compared with those of controls (21.0 6 4.2 mg) and MID
(27.2 6 2.4 mg).
Table 1 shows the T4, T3, and TSH values in maternal and
fetal plasma. In MID, maternal plasma T4 was decreased to
60% of MID1I and decreased below detection limit (,1.5
nm) in the MID1P group at 21 days of gestation. Plasma TSH
increased 103 in MID1P. The plasma T3 concentrations did
not change. Similar changes were observed at days 18 and 21
of gestation.
In the fetal plasma, we found changes comparable with
those described for the mothers: a decrease in T4 concentra-
tion in MID, with T4 being below detection limit in MID1P,
TABLE 1. Concentrations of T4, T3, and TSH in maternal and
fetal plasma
MID1I MID MID1P
At 21 days of gestation
Maternal
T4 nM 20.1 6 4.5 12.1 6 2.9
a ,1.5a
T3 nM 0.66 6 0.11 0.70 6 0.03 0.66 6 0.05
TSH ng/ml 0.43 6 0.08 0.75 6 0.15 3.95 6 0.86a
Fetal
T4 nM 6.7 6 0.6 3.4 6 0.5
a ,1.5a
T3 nM 0.06 6 0.02 0.06 6 0.02 0.08 6 0.02
TSH ng/ml 0.9 6 0.2 1.0 6 0.2 4.5 6 0.5a
At 18 days of gestation
Concentrations of T4, T3 and TSH in maternal plasma
T4 nM 24.3 6 3.2 17.7 6 2.9
a 4.8 6 2.5a
T3 nM 0.75 6 0.06 0.68 6 0.05 0.72 6 0.03
TSH ng/ml 0.44 6 0.08 1.03 6 0.18a 4.95 6 0.70a
a At least P , 0.05 vs. MID1I.
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together with an unchanged plasma T3; an increase in plasma
TSH was only observed in MID1P.
Deiodinase activities
Liver. The developmental pattern, an increase in activity from
day 18 to day 21, was present in all three groups. Hepatic D1
activity was not affected by MID and MID1P either on day
18 or on day 21 (Fig. 1).
BAT. No D2 activity could be measured at day 18, whereas
it was clearly detected on day 21. The mean value of D2
activity was slightly higher at day 21 in MID, compared with
MID1I, but the difference was not statistically significant. A
marked increase in D2 activity was present in MID1P at day
21 (Fig. 2).
Brain. An increase in D2 activity was seen during develop-
ment, from day 18 to day 21. At day 18, no statistically
significant increases in D2 activity were found in MID and
MID1P. At day 21, D2 activity clearly was increased in
MID1P (but not in MID) fetuses.
In brain, the D3 activity at day 18 decreased in MID, and
further in MID1P fetuses, to 30% of MID1I values. On the
contrary, at day 21, the D3 activity increased 2-fold, both in
MID and MID1P (Fig. 3).
Fetal side of the placenta. D3 activity was lower at day 21 than
at day 18 in all three groups (Fig. 4).
D2 activity increased marginally (but significantly) in
MID1P at day 18. This increase in D2 activity was not found
at day 21. The same increase in D3 activity was observed in
MID1P at day 18.
Maternal placenta. There were no changes in D2 and D3 ac-
tivities in the maternal basal side of the placenta caused by
either gestational age or by MID and MID1P (Fig. 5).
D2 activity in the maternal side of the placenta was found
to be about 10 times higher than in the fetal side of the
placenta, whereas D3 activities were comparable.
At day 18, D3 activities in the fetal and maternal placenta
were similar, but they differed at day 21, when the activity
in the maternal placenta was much higher than in the fetal
side.
Skin. D1 activity was not present in measurable amounts in
fetal skin. The changes in D2 and D3 activity in fetal skin are
presented in Fig. 6. The developmental increase in D2 ac-
tivity, from day 18 to day 21, was present in all three groups.
Not only is D2 activity present in the fetal skin, but it in-
creased in MID fetuses and further increased 3- to 4-fold in
MID1P, both at day 18 and at day 21.
The pattern was different for D3 activity in fetal skin. At
day 18, the D3 activity increased almost 2-fold in MID and
in MID1P fetuses, whereas at day 21, a sharp decrease in D3
activity was found: in MID fetuses, the activity was 50% of
the MID1I value; and in MID1P fetuses, it was 30% of the
MID1I value.
FIG. 1. Hepatic D1 activities in fetuses at day 18 and day 21 in
MID1I, MID, and MID1P. Values are the means 6 SE. n 5 8 fetal
livers. For this and the following figures: *, statistically significant
difference at a given age, with respect to MID1I; &, statistically
significant difference between MID and MID1P; #, statistically sig-
nificant difference for a given group between 18 and 21 days.
FIG. 2. D2 activity in fetal BAT at day 21. ND, BAT of 18 days was
not present. Values are the means 6 SE. *, At least P , 0.05 (n 5 8
fetal BAT); *, statistically significant difference, at a given age, with
respect to MID1I; &, statistically significant difference between MID
and MID1P.
FIG. 3. D2 activity (left panel) and D3 activity (right panel) in brain
from 18- and 21-day-old fetuses. Values are the means 6 SE. n 5 8 fetal
brains. *, #, and &, as explained in Fig. 1 legend.
FIG. 4. D2 activity (left panel) and D3 activity (right panel) in the
fetal side of the placentas from 18- and 21-day-old fetuses. Values are
the means 6 SE. n 5 8 fetal placentas. *, #, and &, as explained in Fig.
1 legend.
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An inverse logarithmic relationship was found between
the D2 activity and the T4 concentration in skin, both at day
18 and at day 21 (Fig. 7). A different sensitivity of D2 activity
to changes in the concentration of T4 is observed at both
gestational days. This suggests that the activity of the enzyme
is suppressed by smaller amounts of T4 at day 18. T4 con-
centration in the fetal skin increased from day 18 to day 21,
and it decreased in the MID fetuses and was more pro-
nounced in the MID1P group (Fig. 8). The T3 concentration
responded in an opposite manner to MID and MID1P, with
a decrease at day 18 and an increase at day 21.
Discussion
The plasma T4, T3, and TSH levels of the MID1I rats are
comparable with the plasma levels of rats on a commercial
pellet diet and with those of rats in kinetic experiments
receiving potassium iodide (10 mg/liter) in their drinking
water to prevent reuse of labeled iodide by the thyroid (44).
The degree of ID in this study was not as marked as that
reported in previous studies (6, 12, 13, 24–27). Using the AIN
diet, without adding extra iodine, we induced a marginal ID.
As was seen from the urinary iodine excretion in MID, the
rats received some iodine, probably from the casein in the
AIN diet (23). This degree of ID can be compared with that
occurring in large parts of the world, where endemic goitre
exists because of the low intake of iodine, often aggravated
by the interference of other nutritional or environmental
factors with the iodine-uptake, organification, and thyroid
hormone secretion (45).
The diet, together with 0.005% perchlorate (200 times less
than the amount that is goitrogenic), resulted in the mod-
erately severe ID, with undetectable plasma T4, high TSH,
but still normal T3 levels in rat mothers and their fetuses. This
degree of ID was less than reported in previous studies (6,
12, 13, 24–27) using a Remington-type diet, and in which fetal
plasma T3 decreased.
The normal T3 levels in ID in adult rats has long been
known (12, 22–26, 29–32). How can the normal T3 levels in
the mild and moderately severe ID fetus be explained, con-
sidering that the maternal supply of T4 is so much lower than
in the normal situation, and that maternal-to-fetal transfer of
T3 is not sufficient to ensure normal fetal plasma T3 (19)? One
explanation can be the increase in fetal thyroidal T3 secretion.
In the adult rat, TSH-stimulated D1 activity in the thyroid
(33); D1 activity was increased in the thyroid during ID (29).
But it is not known whether this is the case in the fetal
thyroid. The finding that the fetal thyroid is not stimulated
to increase iodine uptake gives the impression that the fetal
thyroid is not yet fully responsive to TSH (46). Another
FIG. 7. An inverse relationship was present between D2 activity and
the T4 concentration in the skin. As T4 content decreased, D2 activity
increased, both at day 18 (open symbols) and day 21 (filled symbols).
Each correlation is obtained using the mean values obtained from
fetal samples from each dam of the three experimental groups (the
total number is 24 for each correlation) and the SE for the mean of the
fetal values from each dam. MID1I, diamonds; MID, circles; MID1P,
squares. The slope of the linear regression at day 18 is significantly
different from that at day 21 (P , 0.0001, t 5 9.7, df 5 8). Values for
the slopes are 20.419 6 0.026 at day 18; 20.086 6 0.018 at day 21.
FIG. 8. In the left panel, fetal skin T3 concentrations are shown at day
18 and at day 21 in MID1I, MID, and MID1P. In the right panel, skin
T4 concentrations are presented at day 18 and at day 21 in MID1I,
MID, and MID1P. For both panels, values are the means 6 SE. *, at
least P , 0.05; n 5 6–8 fetal skins. *, #, and &, as explained in Fig.
1 legend.
FIG. 5. D2 activity (left panel) and D3 activity (right panel) in the
maternal side of placentas from 18- and 21-day-old fetuses. Values are
the means 6 SE. n 5 8 maternal placentas.
FIG. 6. D2 activity (left panel) and D3 activity (right panel) in fetal
skin from 18- and 21-day-old fetuses. Values are the means 6 SE. n 5
8 fetal skins. *, #, and &, as explained in Fig. 1 legend.
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possibility is that extrathyroidal responses of the iodothy-
ronine deiodinases contribute to this phenomenon.
Until now, D2 activity had been found in the central ner-
vous system, pituitary gland, BAT, pineal gland, placenta,
and muscle. Although Kaplan et al. (42) showed the presence
of D2 in human cultured epidermal keratinocytes from the
neonate and adult, no activity was found in homogenates of
fresh fetal or cadaveric epidermis. But because the skin is a
large part of the body mass in the fetus (15%), it thus seemed
an interesting target for our study.
This is the first time that the presence of D2 activity in the
fetal rat skin is reported. It seems to be higher than D2
activities in fetal brain, and moreover, it responds to degrees
of ID that do not affect brain or BAT D2, and it does so
already at day 18. Because D2 is of crucial importance for
both local production of T3 in particular tissues and systemic
thyroid hormone homeostasis, and because BAT D2 is con-
sidered responsible for a large proportion of the circulating
T3 under hypothyroid conditions (47), the role of the skin in
producing T3 has to be taken into account. Because of the total
mass of the skin, the D2 activity might contribute, in an
important way, not only to the skin T3 content but eventually
also to the plasma T3, especially in situations in which the
maternal supply of T4 is lowered. As can be calculated, the
amount of T3 in skin is 11.6% of the total amount of T3 in the
extrathyroidal fetal pool, as measured by RIA (unpublished
data), much more than brain (5.8%), or even BAT (1.8%).
In addition to the availability of T4 in fetal tissues during
gestation and the level of ID, D3 activity also plays an im-
portant role in fetal skin in regulating T3 levels by inactivat-
ing the biological active thyroid hormone. There is no sig-
nificant difference between the T3 concentration in skin
between day 18 and day 21 in MID1I, whereas there is a clear
and significant increase in MID and MID1P from day 18 to
day 21. Based only on D2 and D3 activity, we cannot find a
cause for this discrepancy.
At day 18, D3 increases in ID, which explains the lowering
of the T3 levels in the skin. But at day 21, a sharp decrease
in D3 activity is found in MID and MID1P, resulting in
higher than normal levels of T3 in this tissue; and so, the skin
might contribute to systemic T3. Skin T4 levels decreased in
accordance with the decrease in T4 in other tissues (plasma,
brain, and liver) during ID (6, 12, 13, 25). The inverse rela-
tionship between T4 and D2 was found at both 18 and 21
days. This had been previously shown on day 21 in BAT (8)
and brain (7) in hypo and hyperthyroidism. Interesting is the
fact that in skin, the changes in D2 and D3 activity are already
pronounced in MID on day 18, whereas such an effect was
not found in brain, suggesting an earlier maturation of the
skin.
D1 activity in liver did not change, indicating a diminished
T3 production caused by the lowered availability in substrate
(T4), as was described in the adult and fetal rat (6, 29). D2
activity in brain and BAT increased in MID1P, in agreement
with previous findings, at day 21, under conditions of severe
ID (6, 12–13, 18, 27). Present data show that MID is not
enough to elicit a D2 response in the fetal brain and BAT,
even at day 21. But even MID is enough to affect D3 activity
at both day 18 and day 21. The decrease in cerebral D3
activity at day 18 is as expected in situations where lower T3
levels occur. But at day 21, there is an unexpected increase
in D3 activity in MID and MID1P, counteracting the increase
of D2, at least in MID1P. No information is available about
the response of D3 in MID and severe ID. An essential aspect
can be that, at a certain time-point, one tissue will be more
mature than the other. This may cause differences in behav-
ior and regulation of activity levels of D3 in tissues such as
skin and brain. Moreover, changes in growth factors might
influence the developmental patterns in tissues (48). The
induction of D3 activity by growth factors is stronger than
that caused by thyroid status. So, a minor change in growth
factor (increase in D3) at a given age can have a more im-
portant impact on D3 activity than thyroid status (decrease
in D3) (49).
D2 activity increased in the the fetal side of the placenta at
day 18. A developmental pattern of D2 was not observed in
the placenta, in contrast to D3. The developmental decrease
in D3 activity was found in the fetal side of the placenta, in
accordance with McCann et al. (2). In our study, there is no
clear role for D2 and D3 in the placenta, for the regulation of
plasma T3 levels. The absence of an effect in maternal pla-
centa might indicate that D2 and D3 activities in this tissue
are regulated by plasma T3. This was also shown in human
placenta during hypothyroidism (50).
Summary and conclusions
Mild and moderate ID caused a decrease in T4 concentra-
tions, although the developmental increase from day 18 to
day 21 was still observed. In spite of the lowered amount of
substrate, the marked increased D2 and decreased D3 activ-
ities at day 21 resulted in higher than normal intracellular T3
concentrations. T3 can remain entirely in the skin itself, but
there might be a net outflux of T3 into the circulation.
The presence of D2 in a tissue is considered an indication
that this tissue needs local production of T3 (as is the case of
brain and BAT). These results show that high D2 activity is
present in fetal skin, even higher than in fetal brain. Because
the activity is increased (as early as day 18) during both mild
and moderately severe ID, it can be concluded that skin D2
is likely to be of considerable physiological importance, at
least for fetal thyroid hormone economy, by contributing to
the intracellular T3 content of the skin, for its own develop-
ment and possibly by contributing to the plasma T3. The
latter would be a benefit for those tissues dependent on
plasma T3, but not for the brain, because this organ is mainly
dependent on T4 and its own D2 for its intracellular T3
concentration.
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